Predicta Biosciences

United States
Panora, Iowa, United States

Company profile

Predicta Biosciences company profile

Predicta Biosciences delivers molecular diagnostics, artificial intelligence tools, and immunotherapeutic discovery services for hematological diseases. It operates a platform that uses whole-genome sequencing of bone marrow biopsies and circulating tumor cells to replace conventional assays and support high-resolution disease monitoring. The company complements genomic data with multiomic immune profiling to inform personalized therapy decisions. Its AI/ML engine mines a growing patient database to uncover novel therapeutic targets. Its focus includes diagnostics across patient disease progression and internal immunotherapy development.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2023-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$28.6M
Last funding
Series A / $23.4M / 2025-10-01
Last equity funding
Series A / $23.4M
Investors
8
Lead investors
1
Founders
5
Articles
15

Founders and investors

Founders

Gad GetzIrene GhobrialKeith FlahertyKenneth AndersonRomanos Sklavenitis-Pistofidis

Lead investors

Engine Ventures

Investors

Binney Street CapitalBrightEdge - American Cancer SocietyEngine VenturesIllumina VenturesMass General Brigham Ventures